(function(){ var content_array=["

关于<\/b> Gene Solutions <\/b><\/p> \n

Gene Solutions 是亚洲领先的生物技术公司,专注于利用先进的人工智能和 ctDNA 技术开发创新的癌症检测解决方案。该公司与东南亚超过 4500 家医院和诊所合作,拥有约 250 名生物学专家和技术人员,员工总数超过700 名。Gene Solutions 发表了超过 50 篇同行评审的出版物,并在该地区开展了超过 50 项多中心研究。该公司因其专有研究以及在新加坡和越南获得 CAP 认证的实验室而受到认可,将多组学与人工智能驱动的方法相结合,致力于转变癌症护理模式。<\/p> \n

媒体咨询请联系:Gene Solutions 媒体联系人
Ms. Emma Ngo<\/span>
www.genesolutions.com<\/a>
邮箱:
pr@genesolutions.com<\/a><\/p> \n

References:<\/b> <\/p> \n

\n \n \n \n \n \n \n \n \n \n \n

(1) <\/i>Chiu, C., & Yang, P. (2024). Challenges of lung cancer control in Asia. EClinicalMedicine, 74, 102706. doi.org\/10.1016\/j.eclinm.2024.102706<\/i> <\/span><\/p> <\/td> \n <\/tr> \n

(2) <\/i>Pozzessere, C.; von Garnier, C.; Beigelman-Aubry, C. Radiation Exposure to Low-Dose Computed Tomography for Lung Cancer Screening: Should We Be Concerned? Tomography 2023, 9, 166-177. doi.org\/10.3390\/tomography9010015<\/i><\/span><\/p> <\/td> \n <\/tr> \n

(3) <\/i>Kerpel-Fronius, A., Tammemägi, M., Cavic, M., Henschke, C., Jiang, L., Kazerooni, E., Lee, C., Ventura, L., Yang, D., Lam, S., Huber, R. M., Yang, D., Zulueta, J., Viola, L., Mohan, A., Lee, C., Cavic, M., Schmidt, H., Kazerooni, E., . . . Huber, R. (2021). Screening for lung cancer in Individuals who Never smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee report. Journal of Thoracic Oncology, 17(1), 56–66. https:\/\/doi.org\/10.1016\/j.jtho.2021.07.031<\/a><\/u><\/i> <\/span><\/p> <\/td> \n <\/tr> \n

(4) <\/i>Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019). Global Epidemiology of Lung Cancer. Annals of Global Health, 85(1). https:\/\/doi.org\/10.5334\/aogh.2419<\/i> <\/span><\/p> <\/td> \n <\/tr> \n

(5) Barta JA, et al. Global Epidemiology of Lung Cancer. Annals of Global Health. (2019). 85(1): 8, 1–16. DOI: https:\/\/doi. org\/10.5334\/aogh.2419<\/i> <\/span><\/p> <\/td> \n <\/tr> \n

(6)<\/i> GLOBOCAN (2020). <\/i> <\/span><\/p> <\/td> \n <\/tr> \n

(7) Nguyen, Van Thien Chi et al. Cost-Effective Shallow Genome-Wide Sequencing for Profiling Plasma cfDNA Signatures to Enhance Lung Cancer Detection (January 11, 2025). dx.doi.org\/10.2139\/ssrn.5094108<\/i><\/span><\/p> <\/td> \n <\/tr> \n

(<\/i>8<\/i>) American College of Radiology <\/i>(<\/i>2022<\/i>)<\/i>.<\/i><\/span><\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n

\n<\/div>"]; $("#dvExtra").html(content_array[0]);})();